Overview
Current NAV
17.5160
As on 30-Dec-2025
Fund Size
2,010.775 Cr
Managed by Nikhil Mathur
Expense Ratio
0.94%
Latest reported
Exit Load Rules
2
Conditions apply
Scheme Snapshot
This growth scheme operates in the equity small cap category with a risk profile of Very High Risk. Inception date 04-Oct-2023. Use the navigation above to explore performance, risk, portfolio holdings, analysis & exit load structure.
Data shown is for informational purposes only and may be delayed.
Returns
Green = Positive, Red = Negative| Period | Absolute % | CAGR % | Category % | Index % |
|---|---|---|---|---|
| 1D | -0.72 | — | — | — |
| 1W | -1.56 | — | — | — |
| 1M | -2.36 | — | — | — |
| 3M | 2.32 | — | 1.47 | — |
| 6M | 3.45 | — | 0.20 | — |
| 1Y | 3.13 | — | -2.14 | — |
| 3Y | — | — | 22.11 | — |
| 5Y | — | — | 14.61 | — |
| 10Y | — | — | — | — |
Top Holdings
Portfolio Allocation (Top 8+)
Company
Nature
Sector
% of Corpus
Sun Pharmaceutical Industries Ltd.
EQ
Healthcare
11.34
Divi's Laboratories Ltd.
EQ
Healthcare
8.34
Lupin Ltd.
EQ
Healthcare
6.40
Glenmark Pharmaceuticals Ltd.
EQ
Healthcare
6.09
Max Healthcare Institute Ltd.
EQ
Healthcare
6.07
Alkem Laboratories Ltd.
EQ
Healthcare
5.89
Ipca Laboratories Ltd.
EQ
Healthcare
4.61
Laurus Labs Ltd.
EQ
Healthcare
4.02
Anthem Biosciences Ltd.
EQ
Healthcare
3.89
Torrent Pharmaceuticals Ltd.
EQ
Healthcare
3.71
Aster DM Healthcare Ltd.
EQ
Healthcare
3.56
Krishna Institute of Medical Sciences Ltd
EQ
Healthcare
3.35
Analysis Highlights
PROS
Lower expense ratio: 0.94%
PROS
1Y annualised returns higher than category average by 5.27%
Exit Load
- Exit load of 1%, if redeemed within 30 days.2024-01-01
- Exit load of 1%, if redeemed within 1 year.2023-09-14